Cargando…

Non-alcoholic fatty liver disease: leading the fight in primary care

Detalles Bibliográficos
Autores principales:	Theodoreson, Mark D, Darnton, Richard, Rowe, Ian, Parker, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal College of General Practitioners 2022
Materias:	Clinical Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512439/ http://dx.doi.org/10.3399/bjgp22X720917

Ejemplares similares

Position statement on the diagnosis and management of non-alcoholic fatty liver disease
por: Alswat, Khalid A., et al.
Publicado: (2019)

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
Publicado: (2016)

Current and Future Treatments in the Fight against Non-Alcoholic Fatty Liver Disease
por: Smeuninx, Benoit, et al.
Publicado: (2020)

Emerging Diagnostics and Therapeutics for Non-alcoholic Fatty Liver Disease
por: Darbhanga, Jake, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website
por: Wallace, Paul, et al.
Publicado: (2017)

Association of fat-to-muscle ratio with non-alcoholic fatty liver disease: a single-centre retrospective study
por: Yan, Fengqin, et al.
Publicado: (2023)

The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Abe, Rose Anne M, et al.
Publicado: (2021)

Fighting non-communicable diseases in East Africa: assessing progress and identifying the next steps
por: Kraef, Christian, et al.
Publicado: (2020)

The microbiome in non-alcoholic fatty liver disease: associations and implications
por: Lin, Eugenia A., et al.
Publicado: (2014)

Cardiovascular disease in patients with non-alcoholic fatty liver disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

A randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website (EFAR-FVG): the study protocol
por: Struzzo, Pierluigi, et al.
Publicado: (2013)

Recognising and diagnosing Cushing’s syndrome in primary care: challenging but not impossible
por: Scoffings, Kate, et al.
Publicado: (2022)

Ready for a long fight against the COVID-19 outbreak: an innovative model of tiered primary health care in Taiwan
por: Chang, Brian Bih-Jeng, et al.
Publicado: (2020)

The association of vitamin D deficiency with non-alcoholic fatty liver disease
por: Küçükazman, Metin, et al.
Publicado: (2014)

Ketamine misuse: an update for primary care
por: Beerten, Simon Gabriël, et al.
Publicado: (2023)

Prevalence, Metabolic Profile, and Associated Risk Factors of Non-alcoholic Fatty Liver Disease in an Adult Population of India
por: Singhai, Abhishek, et al.
Publicado: (2023)

Transcriptome changes in stages of non-alcoholic fatty liver disease
por: Aljabban, Jihad, et al.
Publicado: (2022)

Digital public health leadership in the global fight for health security
por: AlKnawy, Bandar, et al.
Publicado: (2023)

Using intestinal flora to distinguish non-alcoholic steatohepatitis from non-alcoholic fatty liver
por: Li, Chao, et al.
Publicado: (2020)

Face mask - An essential armour in the fight of India against COVID-19
por: Panda, Samiran, et al.
Publicado: (2021)

Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis
por: Al Danaf, Layal, et al.
Publicado: (2022)

Smoker, ex-smoker or non-smoker? The validity of routinely recorded smoking status in UK primary care: a cross-sectional study
por: Marston, Louise, et al.
Publicado: (2014)

Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients
por: Hu, Yanjin, et al.
Publicado: (2016)

REM sleep behaviour disorder: the importance of early identification in primary care
por: Bramich, Samantha, et al.
Publicado: (2022)

Recognising and managing childhood onset uveitis: a guide for primary care
por: Kelly, Eleanor, et al.
Publicado: (2023)

Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis
por: Amonker, Sachin, et al.
Publicado: (2023)

Non-invasive diagnosis of steatosis, inflammatory changes and liver fibrosis in patients with non-alcoholic fatty liver diseases. Pilot study
por: Ciećko-Michalska, Irena, et al.
Publicado: (2018)

Ear wax management in primary care: what the busy GP needs to know
por: Munro, Kevin J, et al.
Publicado: (2023)

Childhood bone tumours in primary care: helping GPs to identify ‘the needle in the haystack’
por: Shanmugavadivel, Dhurgshaarna, et al.
Publicado: (2023)

The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
por: Fouad, Yasser, et al.
Publicado: (2022)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

The impact of primary biliary cholangitis on non-alcoholic fatty liver disease
por: Iluz-Freundlich, Daniel, et al.
Publicado: (2020)

New NICE guidance on acne vulgaris: implications for first-line management in primary care
por: Wilcock, Jane, et al.
Publicado: (2021)

Deterioration of Heart Rate Recovery Index in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Ozveren, Olcay, et al.
Publicado: (2014)

Association between Cardiorespiratory Fitness, Relative Grip Strength with Non-Alcoholic Fatty Liver Disease
por: Hao, Li, et al.
Publicado: (2020)

Screening for primary aldosteronism in primary care
por: Dubrofsky, Lisa, et al.
Publicado: (2023)

Alcohol consumption in Spanish primary health care providers: a national, cross-sectional study
por: Romero-Rodríguez, Esperanza, et al.
Publicado: (2019)

Novel therapeutic targets for cholestatic and fatty liver disease
por: Trauner, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f7qf8lhu9o8m79bmdlpm5rjjlp